Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002016058-24-000002
Filing Date
2024-03-22
Accepted
2024-03-22 12:38:03
Documents
2
Period of Report
2024-03-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1587
2 TSEPOA tsepoa.txt EX-24 4774
  Complete submission text file 0002016058-24-000002.txt   8023
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Issuer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
SIC: 0000

Mailing Address C/O ABRDN 1900 MARKET STREET, SUITE 200 PHILADELPHIA PA 19103
Business Address
Tse Loretta (Reporting) CIK: 0002016058 (see all company filings)

Type: 3 | Act: 34 | File No.: 811-06565 | Film No.: 24774418